Comparison of long-term efficacy between biological agents following tumor necrosis factor inhibitor failure in patients with rheumatoid arthritis: a prospective cohort study

BACKGROUND: Currently, there is contradictory evidence regarding the best strategy to follow after discontinuation of a first biological agent in patients with rheumatoid arthritis (RA). We aimed to compare the long-term efficacy of switching to a second tumor necrosis factor inhibitor (TNFi) versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogas, Patricia, Plasencia-Rodriguez, Chamaida, Navarro-Compán, Victoria, Tornero, Carolina, Novella-Navarro, Marta, Nuño, Laura, Martínez-Feito, Ana, Hernández-Breijo, Borja, Balsa, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641114/
https://www.ncbi.nlm.nih.gov/pubmed/34868357
http://dx.doi.org/10.1177/1759720X211060910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641114/
https://www.ncbi.nlm.nih.gov/pubmed/34868357
http://dx.doi.org/10.1177/1759720X211060910

Ejemplares similares